Pharmacogenomics Global Market Report 2025

Global Pharmacogenomics Market Report 2025

Pharmacogenomics Global Market Report 2025 – By Technology (Next Generation Sequencing, Polymerase Chain Reaction, Gel Electrophoresis, Mass Spectrometry, Microarray, Other Technologies), By Application (Neurological Diseases, Infectious Diseases, Oncology, Cardiovascular Diseases, Pain Management, Other Applications), By End User (Hospitals and Clinics, Research Institutions, Academic Institutes, Other End Users) – Market Size, Trends, And Global Forecast 2025-2034

Name: Pharmacogenomics Global Market Report 2025
Creator: The Business Research Company
License: https://www.thebusinessresearchcompany.com/privacy-policy

Pharmacogenomics Global Market Report 2025

Report Price : $4490.00 | Pages : 200 | Published : January 2025 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options

Request a Sample

Request For Discount

Customise Your Report

Item added to cart!

Request For Proposal

Request For Regional Data

FAQs

Need assistance or more information before the purchase?

Enquire Before Buying

Pharmacogenomics Global Market Report 2025

Proud Members Of

What Is Covered Under Pharmacogenomics Market?

Pharmacogenomics is a field of research that studies how a patient's genes affect and how they respond to medications. The long-term aim of pharmacogenomics is to help doctors select the drugs and doses best suited for each person. Pharmacogenomics is used to create customized drugs to treat a variety of health issues, including cardiovascular disease, Alzheimer's disease, cancer, and asthma. The pharmacogenomics marker refers to precise medical treatment for each person or a group of people.

The main technologies used in the pharmacogenomics market a next-generation sequencing (NGS), polymerase chain reaction, gel electrophoresis, mass spectrometry, microarray, and other technologies. NGS is a massively parallel sequencing technology that provides ultra-high throughput, scalability, and speed. The technology is used to determine the nucleotide order in entire genomes or specific regions of DNA or RNA. The application of pharmacogenomics includes neurological diseases, infectious diseases, oncology, cardiovascular diseases, pain management, and other applications. The end-users included hospitals and clinics, research institutions, academic institutes, and others.

Pharmacogenomics Market Size and growth rate 2025 to 2029: Graph

What Is The Pharmacogenomics Market Size 2025 And Growth Rate?

The pharmacogenomics market size has grown rapidly in recent years. It will grow from $8.94 billion in 2024 to $9.92 billion in 2025 at a compound annual growth rate (CAGR) of 10.9%. The growth in the historic period can be attributed to strong economic growth in emerging markets, the increasing focus on personalized medicine, the rising advanced healthcare infrastructure and increased healthcare expenditure.

What Is The Pharmacogenomics Market Growth Forecast?

The pharmacogenomics market size is expected to see rapid growth in the next few years. It will grow to $14.81 billion in 2029 at a compound annual growth rate (CAGR) of 10.5%. The growth in the forecast period can be attributed to the increasing aging population, the increasing chronic diseases, the rising population and the increasing demand for cancer treatment. Major trends in the forecast period include launch of genome editing solution for deeper analysis of advanced therapies, focus on integration of artificial intelligence (AI) in genomics to analyze genetic data, growing advancements in metagenomics, strategic partnerships and collaborations among market players, introduction of three-dimensional (3D) genomics to study influences on gene expression and function, new product innovations with focus on infectious diseases and gene editing and development of psychotropic pharmacogenomics test for informed decisions.

Book your 30 minutes free consultation with our research experts

How Is The Pharmacogenomics Market Segmented?

The pharmacogenomics market covered in this report is segmented –

1) By Technology: next generation sequencing, Polymerase Chain Reaction, Gel Electrophoresis, Mass Spectrometry, Microarray, Other Technologies

2) By Application: Neurological Diseases, Infectious Diseases, Oncology, Cardiovascular Diseases, Pain Management, Other Applications

3) By End User: Hospitals and Clinics, Research Institutions, Academic Institutes, Other End Users

Subsegments:

1) By Next Generation Sequencing (NGS): Whole Genome Sequencing, Targeted Sequencing, Exome Sequencing

2) By Polymerase Chain Reaction (PCR): Quantitative PCR (qPCR), Reverse Transcription PCR (RT-PCR), Digital PCR

3) By Gel Electrophoresis: Agarose Gel Electrophoresis, Polyacrylamide Gel Electrophoresis, Capillary Gel Electrophoresis

4) By Mass Spectrometry: LC-MS/MS (Liquid Chromatography-Tandem Mass Spectrometry), MALDI-TOF MS (Matrix-Assisted Laser Desorption/Ionization Time of Flight), HRMS (High-Resolution Mass Spectrometry)

5) By Microarray: SNP Microarrays, Expression Microarrays, Comparative Genomic Hybridization (CGH) Arrays

6) By Other Technologies: Sanger Sequencing, CRISPR-Based Technologies, Bioinformatics Tools

What Is Driving The Pharmacogenomics Market? Precision Medicine's Surge And Its Impact On The Growing Pharmacogenomics Market

The rising demand for precision medicine is driving the demand for the pharmacogenomics market. Precision medicine is a medical model that proposes healthcare customization, with medical decisions, treatments, practices, or products tailored to a subset of patients rather than a one-drug-fits-all model. There is a rising demand for precision medicine as IT is the most advanced in oncology, having wider, exciting applications beyond oncology and late-stage diseases such as rare and genetic diseases. The main aim of precision medicine is to integrate genetic and environmental information about particular diseases and/or their responses to particular treatments. For instance, according to the article published on Linchpinseo in March 2022, the increasing demand for precision medicine investment from leading pharmaceutical companies is experiencing a 1/3 increase in the next five years. Furthermore, in the USA, 30 million people with type 2 diabetes get diagnosed and treated where precision medicine provides individualized treatment and will re-calibrate current treatment practices. Hence, the increasing demand for precision medicine will drive the pharmacogenomics market.

What Is Driving The Pharmacogenomics Market? The Proliferation Of Chronic Diseases Fueling Growth In The Pharmacogenomics Market

The increasing number of chronic diseases is expected to propel the growth of the pharmacogenomics market going forward. Chronic diseases are medical conditions that persist over an extended period, often for a person's lifetime. Pharmacogenomics offers a personalized approach to the treatment of chronic diseases, taking into account individual genetic variations that impact drug response. For instance, in September 2023, according to the World Health Organization, a Switzerland-based specialized agency of the United Nations, there were 41 million deaths, which is 74% of those caused by non-communicable diseases (NCDs) or chronic diseases every year globally. There were 17.9 million deaths from cardiovascular diseases, 9.3 million deaths from cancer, 4.1 million deaths from chronic respiratory diseases, and 2.0 million deaths from diabetes. Therefore, the increasing number of chronic diseases is driving the growth of the pharmacogenomics market.

Who Are The Major Players In The Global Pharmacogenomics Market?

Major companies operating in the pharmacogenomics market include Illumina Inc, Eurofins Scientific, Myriad Genetics Inc, PerkinElmer Inc, Centogene N.V, Invitae Corporation, Genomind, Pacific Biosciences of California Inc, Oneome LLC, Admera Health, MapMyGenome, Positive Bioscience, Xcode Life Sciences, Xcelris Labs, Takeda Pharmaceutical Company Limited, Garvan Institute of Medical Research, 3D Medicines Inc, Berry Genomics, BGI, GenomiCare Biotechnology, Bayer AG, GlaxoSmithKline plc (GSK), F Hoffmann-La Roche AG, Merck KGaA, QIAGEN N.V, Centro de Genoma e Biologia de Sistemas (CGBS), Dasa Group, Datar Cancer Genetics Limited, MedGenome Labs, 23andMe, Color Genomics, Pathway Genomics, Laboratório Richet, Laboratório Exame, Genomika Diagnósticos

What Are The Key Trends Of The Global Pharmacogenomics Market? Technological Advancements Transforming The Pharmacogenomics Market

Technological advancement is a key trend gaining the popularity in pharmacogenomics market. Medicine manufacturers are focusing on various approaches to pharmacogenomics analysis to provide cost-effective solutions for screening known polymorphisms and the discovery of novel variants. For instance, in May 2022, Invitae, a US-based medical laboratory organization, launched its expanded Pharmacogenomics Panel. The Invitae Pharmacogenomics (PGx) Panel, including the Mental Health Panel, provides insights into genetic responses to medications across various specialties like primary care, cardiology, and oncology. With nearly 25% of patients facing atypical drug responses due to genetics, PGx testing is set to become a standard practice. Effective integration into healthcare requires enhanced support for providers to understand and apply PGx testing in their clinical settings.

What Are The Key Trends Of The Global Pharmacogenomics Market? Thermo Fisher's Innovation In Infectious Disease Diagnosis And Gene Editing Solutions

Companies operating in the market are focusing on developing new and innovative infectious disease diagnosis and gene editing solutions to strengthen their position in the market. For example, in March 2022, Thermo Fisher Scientific Inc., a US-based supplier of analytical instruments, life sciences solutions, specialty diagnostics, laboratory, pharmaceutical, and biotechnology services, introduced the latest generation of its SeqStudio Flex Series Genetic Analyzer. This innovative tool was designed to enhance research in areas such as infectious disease diagnosis and gene editing. The SeqStudio Flex Genetic Analyzer is built on the gold-standard quality of Capillary Electrophoresis (CE) technology, which enables Sanger sequencing (a method of DNA sequencing based on the selective incorporation of chain-terminating dideoxynucleotides by DNA polymerase during in vitro DNA replication) and fragment analysis (a method for determining the size of a particular DNA fragment). The SeqStudio Flex Genetic Analyzer is available in both 8- and 24-capillary configurations and is designed to deliver high-quality data and reliable performance. It offers a variety of applications, including mitochondrial sequencing, variant detection, point mutation analysis, multiplex PCR, cell line authentication, microsatellite instability, DNA/library quality control, copy number analysis, short tandem repeat (STR) analysis, SNP genotyping, and multiplex ligation-dependent probe amplification (MLPA) assays. The instrument is designed with enhanced flexibility, usability, and connectivity. It has an increased plate capacity and can be loaded at any time without canceling or waiting for a run to complete, improving sample throughput, walk-away capacity, and scheduling flexibility.

Pharmacogenomics Market Merger And Acquisition: Genomenon Expands Genomics Capabilities With Acquisition Of Boston Genetics

In June 2023, Genomenon, a US-based genomics intelligence company, acquired Boston Genetics for an undisclosed amount. The acquisition aims to combine Genomenon's AI-powered genomic platform with Boston Genetics' team of genetic scientists to curate the entire human genome. This acquisition will support clinical diagnostic and pharmaceutical drug development programs by providing valuable insights into the genomic drivers of genetic diseases and oncology. The acquisition also creates a genomics data service arm for Genomenon, allowing the company to provide cost-effective variant curation team extensions for genetic testing labs to speed up their turnaround times. Boston Genetics is a US-based genomics interpretation and curation company.

Regional Outlook For The Global Pharmacogenomics Market

North America was the largest region in the pharmacogenomics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pharmacogenomics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the pharmacogenomics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

What Defines the Pharmacogenomics Market?

The pharmacogenomics market includes revenues earned by entities by providing PennCNV, QuantiSNP, GenoCN, and Nexus. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Pharmacogenomics Industry?

The pharmacogenomics market research report is one of a series of new reports from The Business Research Company that provides pharmacogenomics market statistics, including pharmacogenomics industry global market size, regional shares, competitors with a pharmacogenomics market share, detailed pharmacogenomics market segments, market trends and opportunities, and any further data you may need to thrive in the pharmacogenomics industry. This pharmacogenomics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Pharmacogenomics Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2025	$9.92 billion
Revenue Forecast In 2034	$14.81 billion
Growth Rate	CAGR of 10.5% from 2024 to 2033
Base Year For Estimation	2024
Actual Estimates/Historical Data	2019-2024
Forecast Period	2025 - 2029 - 2034
Market Representation	Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered	1) By Technology: Next Generation Sequencing, Polymerase Chain Reaction, Gel Electrophoresis, Mass Spectrometry, Microarray, Other Technologies 2) By Application: Neurological Diseases, Infectious Diseases, Oncology, Cardiovascular Diseases, Pain Management, Other Applications 3) By End User: Hospitals and Clinics, Research Institutions, Academic Institutes, Other End Users Subsegments: 1) By Next Generation Sequencing (NGS): Whole Genome Sequencing, Targeted Sequencing, Exome Sequencing 2) By Polymerase Chain Reaction (PCR): Quantitative PCR (qPCR), Reverse Transcription PCR (RT-PCR), Digital PCR 3) By Gel Electrophoresis: Agarose Gel Electrophoresis, Polyacrylamide Gel Electrophoresis, Capillary Gel Electrophoresis 4) By Mass Spectrometry: LC-MS/MS (Liquid Chromatography-Tandem Mass Spectrometry), MALDI-TOF MS (Matrix-Assisted Laser Desorption/Ionization Time of Flight), HRMS (High-Resolution Mass Spectrometry) 5) By Microarray: SNP Microarrays, Expression Microarrays, Comparative Genomic Hybridization (CGH) Arrays 6) By Other Technologies: Sanger Sequencing, CRISPR-Based Technologies, Bioinformatics Tools
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled	Illumina Inc, Eurofins Scientific, Myriad Genetics Inc, PerkinElmer Inc, Centogene N.V, Invitae Corporation, Genomind, Pacific Biosciences of California Inc, Oneome LLC, Admera Health, MapMyGenome, Positive Bioscience, Xcode Life Sciences, Xcelris Labs, Takeda Pharmaceutical Company Limited, Garvan Institute of Medical Research, 3D Medicines Inc, Berry Genomics, BGI, GenomiCare Biotechnology, Bayer AG, GlaxoSmithKline plc (GSK), F Hoffmann-La Roche AG, Merck KGaA, QIAGEN N.V, Centro de Genoma e Biologia de Sistemas (CGBS), Dasa Group, Datar Cancer Genetics Limited, MedGenome Labs, 23andMe, Color Genomics, Pathway Genomics, Laboratório Richet, Laboratório Exame, Genomika Diagnósticos
Customization Scope	Request for Sample
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

2. Pharmacogenomics Market Characteristics

3. Pharmacogenomics Market Trends And Strategies

4. Pharmacogenomics Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

5. Global Pharmacogenomics Growth Analysis And Strategic Analysis Framework

5.1. Global Pharmacogenomics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Pharmacogenomics Market Growth Rate Analysis

5.4. Global Pharmacogenomics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Pharmacogenomics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Pharmacogenomics Total Addressable Market (TAM)

6. Pharmacogenomics Market Segmentation

6.1. Global Pharmacogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Next Generation Sequencing

Polymerase Chain Reaction

Gel Electrophoresis

Mass Spectrometry

Microarray

Other Technologies

6.2. Global Pharmacogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Neurological Diseases

Infectious Diseases

Oncology

Cardiovascular Diseases

Pain Management

Other Applications

6.3. Global Pharmacogenomics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospitals and Clinics

Research Institutions

Academic Institutes

Other End Users

6.4. Global Pharmacogenomics Market, Sub-Segmentation Of Next Generation Sequencing (NGS), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Whole Genome Sequencing

Targeted Sequencing

Exome Sequencing

6.5. Global Pharmacogenomics Market, Sub-Segmentation Of Polymerase Chain Reaction (PCR), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Quantitative PCR (qPCR)

Reverse Transcription PCR (RT-PCR)

Digital PCR

6.6. Global Pharmacogenomics Market, Sub-Segmentation Of Gel Electrophoresis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Agarose Gel Electrophoresis

Polyacrylamide Gel Electrophoresis

Capillary Gel Electrophoresis

6.7. Global Pharmacogenomics Market, Sub-Segmentation Of Mass Spectrometry, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

LC-MS/MS (Liquid Chromatography-Tandem Mass Spectrometry)

MALDI-TOF MS (Matrix-Assisted Laser Desorption/Ionization Time of Flight)

HRMS (High-Resolution Mass Spectrometry)

6.8. Global Pharmacogenomics Market, Sub-Segmentation Of Microarray, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

SNP Microarrays

Expression Microarrays

Comparative Genomic Hybridization (CGH) Arrays

6.9. Global Pharmacogenomics Market, Sub-Segmentation Of Other Technologies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Sanger Sequencing

CRISPR-Based Technologies

Bioinformatics Tools

7. Pharmacogenomics Market Regional And Country Analysis

7.1. Global Pharmacogenomics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Pharmacogenomics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Pharmacogenomics Market

8.1. Asia-Pacific Pharmacogenomics Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Pharmacogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Pharmacogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Pharmacogenomics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Pharmacogenomics Market

9.1. China Pharmacogenomics Market Overview

9.2. China Pharmacogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Pharmacogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Pharmacogenomics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Pharmacogenomics Market

10.1. India Pharmacogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Pharmacogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Pharmacogenomics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Pharmacogenomics Market

11.1. Japan Pharmacogenomics Market Overview

11.2. Japan Pharmacogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Pharmacogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Pharmacogenomics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Pharmacogenomics Market

12.1. Australia Pharmacogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Pharmacogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Pharmacogenomics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Pharmacogenomics Market

13.1. Indonesia Pharmacogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Pharmacogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Pharmacogenomics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Pharmacogenomics Market

14.1. South Korea Pharmacogenomics Market Overview

14.2. South Korea Pharmacogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Pharmacogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Pharmacogenomics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Pharmacogenomics Market

15.1. Western Europe Pharmacogenomics Market Overview

15.2. Western Europe Pharmacogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Pharmacogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Pharmacogenomics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Pharmacogenomics Market

16.1. UK Pharmacogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Pharmacogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Pharmacogenomics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Pharmacogenomics Market

17.1. Germany Pharmacogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Pharmacogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Pharmacogenomics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Pharmacogenomics Market

18.1. France Pharmacogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Pharmacogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Pharmacogenomics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Pharmacogenomics Market

19.1. Italy Pharmacogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Pharmacogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Pharmacogenomics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Pharmacogenomics Market

20.1. Spain Pharmacogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Pharmacogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Pharmacogenomics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Pharmacogenomics Market

21.1. Eastern Europe Pharmacogenomics Market Overview

21.2. Eastern Europe Pharmacogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Pharmacogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Pharmacogenomics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Pharmacogenomics Market

22.1. Russia Pharmacogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Pharmacogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Pharmacogenomics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Pharmacogenomics Market

23.1. North America Pharmacogenomics Market Overview

23.2. North America Pharmacogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Pharmacogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Pharmacogenomics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Pharmacogenomics Market

24.1. USA Pharmacogenomics Market Overview

24.2. USA Pharmacogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Pharmacogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Pharmacogenomics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Pharmacogenomics Market

25.1. Canada Pharmacogenomics Market Overview

25.2. Canada Pharmacogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Pharmacogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Pharmacogenomics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Pharmacogenomics Market

26.1. South America Pharmacogenomics Market Overview

26.2. South America Pharmacogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Pharmacogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Pharmacogenomics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Pharmacogenomics Market

27.1. Brazil Pharmacogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Pharmacogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Pharmacogenomics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Pharmacogenomics Market

28.1. Middle East Pharmacogenomics Market Overview

28.2. Middle East Pharmacogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Pharmacogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Pharmacogenomics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Pharmacogenomics Market

29.1. Africa Pharmacogenomics Market Overview

29.2. Africa Pharmacogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Pharmacogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Pharmacogenomics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Pharmacogenomics Market Competitive Landscape And Company Profiles

30.1. Pharmacogenomics Market Competitive Landscape

30.2. Pharmacogenomics Market Company Profiles

30.2.1. Illumina Inc Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Eurofins Scientific Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Myriad Genetics Inc Overview, Products and Services, Strategy and Financial Analysis

30.2.4. PerkinElmer Inc Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Centogene N.V Overview, Products and Services, Strategy and Financial Analysis

31. Pharmacogenomics Market Other Major And Innovative Companies

31.1. Invitae Corporation

31.2. Genomind

31.3. Pacific Biosciences of California Inc

31.4. Oneome LLC

31.5. Admera Health

31.6. MapMyGenome

31.7. Positive Bioscience

31.8. Xcode Life Sciences

31.9. Xcelris Labs

31.10. Takeda Pharmaceutical Company Limited

31.11. Garvan Institute of Medical Research

31.12. 3D Medicines Inc

31.13. Berry Genomics

31.14. BGI

31.15. GenomiCare Biotechnology

32. Global Pharmacogenomics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Pharmacogenomics Market

34. Recent Developments In The Pharmacogenomics Market

35. Pharmacogenomics Market High Potential Countries, Segments and Strategies

35.1 Pharmacogenomics Market In 2029 - Countries Offering Most New Opportunities

35.2 Pharmacogenomics Market In 2029 - Segments Offering Most New Opportunities

35.3 Pharmacogenomics Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2019-2024, $ Billion

Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Table 3: Global Pharmacogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 4: Global Pharmacogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 5: Global Pharmacogenomics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 6: Global Pharmacogenomics Market, Sub-Segmentation Of Next Generation Sequencing (NGS), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 7: Global Pharmacogenomics Market, Sub-Segmentation Of Polymerase Chain Reaction (PCR), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 8: Global Pharmacogenomics Market, Sub-Segmentation Of Gel Electrophoresis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 9: Global Pharmacogenomics Market, Sub-Segmentation Of Mass Spectrometry, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 10: Global Pharmacogenomics Market, Sub-Segmentation Of Microarray, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 11: Global Pharmacogenomics Market, Sub-Segmentation Of Other Technologies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 12: Global Pharmacogenomics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 13: Global Pharmacogenomics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 14: Asia-Pacific, Pharmacogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 15: Asia-Pacific, Pharmacogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 16: Asia-Pacific, Pharmacogenomics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 17: China, Pharmacogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 18: China, Pharmacogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 19: China, Pharmacogenomics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 20: India, Pharmacogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 21: India, Pharmacogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 22: India, Pharmacogenomics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 23: Japan, Pharmacogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 24: Japan, Pharmacogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 25: Japan, Pharmacogenomics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 26: Australia, Pharmacogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 27: Australia, Pharmacogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 28: Australia, Pharmacogenomics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 29: Indonesia, Pharmacogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 30: Indonesia, Pharmacogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 31: Indonesia, Pharmacogenomics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 32: South Korea, Pharmacogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 33: South Korea, Pharmacogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 34: South Korea, Pharmacogenomics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 35: Western Europe, Pharmacogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 36: Western Europe, Pharmacogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 37: Western Europe, Pharmacogenomics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 38: UK, Pharmacogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 39: UK, Pharmacogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 40: UK, Pharmacogenomics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 41: Germany, Pharmacogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 42: Germany, Pharmacogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 43: Germany, Pharmacogenomics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 44: France, Pharmacogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 45: France, Pharmacogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 46: France, Pharmacogenomics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 47: Italy, Pharmacogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 48: Italy, Pharmacogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 49: Italy, Pharmacogenomics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 50: Spain, Pharmacogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 51: Spain, Pharmacogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 52: Spain, Pharmacogenomics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 53: Eastern Europe, Pharmacogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 54: Eastern Europe, Pharmacogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 55: Eastern Europe, Pharmacogenomics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 56: Russia, Pharmacogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 57: Russia, Pharmacogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 58: Russia, Pharmacogenomics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 59: North America, Pharmacogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 60: North America, Pharmacogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 61: North America, Pharmacogenomics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 62: USA, Pharmacogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 63: USA, Pharmacogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 64: USA, Pharmacogenomics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 65: Canada, Pharmacogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 66: Canada, Pharmacogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 67: Canada, Pharmacogenomics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 68: South America, Pharmacogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 69: South America, Pharmacogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 70: South America, Pharmacogenomics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 71: Brazil, Pharmacogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 72: Brazil, Pharmacogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 73: Brazil, Pharmacogenomics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 74: Middle East, Pharmacogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 75: Middle East, Pharmacogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 76: Middle East, Pharmacogenomics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 77: Africa, Pharmacogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 78: Africa, Pharmacogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 79: Africa, Pharmacogenomics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 80: Illumina Inc Financial Performance

Table 81: Eurofins Scientific Financial Performance

Table 82: Myriad Genetics Inc Financial Performance

Table 83: PerkinElmer Inc Financial Performance

Table 84: Centogene N.V Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2019-2024, $ Billion

Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Figure 3: Global Pharmacogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 4: Global Pharmacogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 5: Global Pharmacogenomics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 6: Global Pharmacogenomics Market, Sub-Segmentation Of Next Generation Sequencing (NGS), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 7: Global Pharmacogenomics Market, Sub-Segmentation Of Polymerase Chain Reaction (PCR), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 8: Global Pharmacogenomics Market, Sub-Segmentation Of Gel Electrophoresis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 9: Global Pharmacogenomics Market, Sub-Segmentation Of Mass Spectrometry, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 10: Global Pharmacogenomics Market, Sub-Segmentation Of Microarray, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 11: Global Pharmacogenomics Market, Sub-Segmentation Of Other Technologies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 12: Global Pharmacogenomics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 13: Global Pharmacogenomics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 14: Asia-Pacific, Pharmacogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 15: Asia-Pacific, Pharmacogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 16: Asia-Pacific, Pharmacogenomics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 17: China, Pharmacogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 18: China, Pharmacogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 19: China, Pharmacogenomics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 20: India, Pharmacogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 21: India, Pharmacogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 22: India, Pharmacogenomics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 23: Japan, Pharmacogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 24: Japan, Pharmacogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 25: Japan, Pharmacogenomics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 26: Australia, Pharmacogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 27: Australia, Pharmacogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 28: Australia, Pharmacogenomics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 29: Indonesia, Pharmacogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 30: Indonesia, Pharmacogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 31: Indonesia, Pharmacogenomics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 32: South Korea, Pharmacogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 33: South Korea, Pharmacogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 34: South Korea, Pharmacogenomics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 35: Western Europe, Pharmacogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 36: Western Europe, Pharmacogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 37: Western Europe, Pharmacogenomics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 38: UK, Pharmacogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 39: UK, Pharmacogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 40: UK, Pharmacogenomics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 41: Germany, Pharmacogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 42: Germany, Pharmacogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 43: Germany, Pharmacogenomics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 44: France, Pharmacogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 45: France, Pharmacogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 46: France, Pharmacogenomics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 47: Italy, Pharmacogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 48: Italy, Pharmacogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 49: Italy, Pharmacogenomics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 50: Spain, Pharmacogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 51: Spain, Pharmacogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 52: Spain, Pharmacogenomics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 53: Eastern Europe, Pharmacogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 54: Eastern Europe, Pharmacogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 55: Eastern Europe, Pharmacogenomics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 56: Russia, Pharmacogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 57: Russia, Pharmacogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 58: Russia, Pharmacogenomics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 59: North America, Pharmacogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 60: North America, Pharmacogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 61: North America, Pharmacogenomics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 62: USA, Pharmacogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 63: USA, Pharmacogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 64: USA, Pharmacogenomics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 65: Canada, Pharmacogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 66: Canada, Pharmacogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 67: Canada, Pharmacogenomics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 68: South America, Pharmacogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 69: South America, Pharmacogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 70: South America, Pharmacogenomics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 71: Brazil, Pharmacogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 72: Brazil, Pharmacogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 73: Brazil, Pharmacogenomics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 74: Middle East, Pharmacogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 75: Middle East, Pharmacogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 76: Middle East, Pharmacogenomics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 77: Africa, Pharmacogenomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 78: Africa, Pharmacogenomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 79: Africa, Pharmacogenomics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 80: Illumina Inc Financial Performance

Figure 81: Eurofins Scientific Financial Performance

Figure 82: Myriad Genetics Inc Financial Performance

Figure 83: PerkinElmer Inc Financial Performance

Figure 84: Centogene N.V Financial Performance

The Healthcare Adhesive Tapes Market Share, Market Size, And Growth Rate 2022

What Is The Small Animal Imaging (In-Vivo) Market Overview In 2022?

The Bifurcation Lesions Market Share, Market Size, And Growth Rate 2022

Global Hand-Held Surgical Instruments Market 2022 – Market Opportunities And Strategies

The Business Research Company offers the surgical retractors market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the topical drug delivery market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the single-use assemblies market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the neuroscience antibodies and assays market research report 2022 with industry size, share, segments and market growth

Molecular Diagnostics Global Market Report 2022 – By Technology (Polymerase Chain Reaction (PCR), DNA Sequencing, and Next-Generation Sequencing), By Product (Instruments, Reagents and Consumables, Software and Services), By Application (Oncology, Pharmacogenomics, Infectious Diseases, Genetic Testing, Neurological Disease, Cardiovascular Disease, Microbiology, and Other Applications), By End-User (Hospitals, Laboratories, and Other End-Users (Blood Banks, Home Health Agencies, and Nursing Homes) – Market Size, Trends, And Global Forecast 2022-2026

View Report

Drug Discovery Global Market Report 2025 – By Drug Type (Small Molecule, Large Molecule), By Process (Target Selection, Target Validation, Hit-To-Lead Identification, Lead Optimization, Candidate Validation), By Technology (High Throughput Screening, Spectroscopy, Combinatorial Chemistry, Biochips, Pharmacogenomics and Pharmacogenetics, Bioinformatics, Metabolomics, Nanotechnology, Other Technologies), By Therapeutic Area (Oncology, Neurology, Infectious and Immune System Diseases, Digestive System Diseases, Cardiovascular Diseases, Diabetes, Respiratory Disease, Other Therapeutic Areas), By End User (Pharmaceutical Companies, CROs, Other End-Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Polymerase Chain Reactions (PCR) Devices, Reagents And Uses Global Market Report 2025 – By Product (Instruments, Reagents, Consumables), By Instruments (Standard PCR, RT-PCR, Digital PCR), By End User (Pharmaceutical and biotechnology industries, Clinical Diagnostics labs and hospitals, Academics and research organization) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Point-of-Care Diagnostics Devices And Equipment Global Market Report 2025 – By Type (Infectious disease testing kits, Cardio metabolic monitoring kits, Cholesterol testing kits, Pregnancy and fertility tests kits, Tumor/cancer markers, Urinalysis testing kits, Hematology testing kits, Drugs of abuse testing kits, Fecal occult testing kits, Other Types), By Prescription Mode (Prescription-based Testing Devices, Over-The-Counter (OTC) Testing Devices), By End User (Professional diagnostic centers, Hospitals/critical care centers, Outpatient healthcare Setting, Ambulatory care settings, Research laboratories, Home) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Medical Equipment Global Market Report 2025 – By Type (In-Vitro Diagnostics, Dental Equipment And Supplies, Ophthalmic Devices, Diagnostic Imaging Equipment, Cardiovascular Devices, Hospital Supplies, Surgical Equipment, Orthopedic Devices, Patient Monitoring Devices, Diabetes Care Devices, Nephrology And Urology Devices, ENT Devices, Anesthesia And Respiratory Devices, Neurology Devices, Wound Care Devices), By Type Of Expenditure (Public, Private), By Product (Instruments And Equipment, Disposables And Consumables), By End User (Hospitals And Clinics, Homecare And Diagnostic Centers, Other End Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Point-Of-Care Molecular Diagnostics Global Market Report 2025 – By Product And Service (Assays And Kits, Instruments And Analyzers, Software And Services), By Technology (Reverse Transcription- Polymerase Chain Reaction (RT-PCR), In Situ Hybridization, Sequencing), By Application (Respiratory Diseases, Hospital Acquired Infections (HAIs), Cancer/Oncology, Hepatitis, Hematology), By End-User (Decentralized Labs, Hospitals, Home Care, Assisted Living Healthcare Facilities) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Molecular Diagnostics Devices And Equipment Global Market Report 2025 – By Product (Instruments, Reagents And Consumables, Software), By Technology (DNA (Deoxyribonucleic acid) sequencing, Polymerase chain reaction, Isothermal Nucleic Acid Amplification Technology, Transcription Mediated Amplification (TMA), In situ hybridization, Microarrays, Mass spectrometry, Other Technologies), By Application (Cancer, Pharmacogenomics, Genetic testing, Infectious disease, Prenatal, Other Applications), By End User (Diagnostic laboratories, Hospitals, Other End Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Frequently Asked Questions

What is the definition of the Pharmacogenomics market?

How will the Pharmacogenomics market drivers and restraints affect the market dynamics? What forces will shape the Pharmacogenomics industry going forward?

The Pharmacogenomics market major growth driver - Precision Medicine's Surge And Its Impact On The Growing Pharmacogenomics Market. For further insights on the Pharmacogenomics market, request a sample here

What is the forecast market size or the forecast market value of the Pharmacogenomics market?

The Pharmacogenomics market size has grown strongly in recent years. The pharmacogenomics market size has grown rapidly in recent years. It will grow from $8.94 billion in 2024 to $9.92 billion in 2025 at a compound annual growth rate (CAGR) of 10.9%. The growth in the historic period can be attributed to strong economic growth in emerging markets, the increasing focus on personalized medicine, the rising advanced healthcare infrastructure and increased healthcare expenditure. The pharmacogenomics market size is expected to see rapid growth in the next few years. It will grow to $14.81 billion in 2029 at a compound annual growth rate (CAGR) of 10.5%. The growth in the forecast period can be attributed to the increasing aging population, the increasing chronic diseases, the rising population and the increasing demand for cancer treatment. Major trends in the forecast period include launch of genome editing solution for deeper analysis of advanced therapies, focus on integration of artificial intelligence (AI) in genomics to analyze genetic data, growing advancements in metagenomics, strategic partnerships and collaborations among market players, introduction of three-dimensional (3D) genomics to study influences on gene expression and function, new product innovations with focus on infectious diseases and gene editing and development of psychotropic pharmacogenomics test for informed decisions. For further insights on the Pharmacogenomics market, request a sample here

How is the Pharmacogenomics market segmented?

The pharmacogenomics market covered in this report is segmented –
1) By Technology: Next Generation Sequencing, Polymerase Chain Reaction, Gel Electrophoresis, Mass Spectrometry, Microarray, Other Technologies
2) By Application: Neurological Diseases, Infectious Diseases, Oncology, Cardiovascular Diseases, Pain Management, Other Applications
3) By End User: Hospitals and Clinics, Research Institutions, Academic Institutes, Other End Users Subsegments:
1) By Next Generation Sequencing (NGS): Whole Genome Sequencing, Targeted Sequencing, Exome Sequencing
2) By Polymerase Chain Reaction (PCR): Quantitative PCR (qPCR), Reverse Transcription PCR (RT-PCR), Digital PCR
3) By Gel Electrophoresis: Agarose Gel Electrophoresis, Polyacrylamide Gel Electrophoresis, Capillary Gel Electrophoresis
4) By Mass Spectrometry: LC-MS/MS (Liquid Chromatography-Tandem Mass Spectrometry), MALDI-TOF MS (Matrix-Assisted Laser Desorption/Ionization Time of Flight), HRMS (High-Resolution Mass Spectrometry)
5) By Microarray: SNP Microarrays, Expression Microarrays, Comparative Genomic Hybridization (CGH) Arrays
6) By Other Technologies: Sanger Sequencing, CRISPR-Based Technologies, Bioinformatics Tools For further insights on the Pharmacogenomics market, request a sample here

Which region has the largest share of the Pharmacogenomics market? What are the other regions covered in the report?

North America was the largest region in the pharmacogenomics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pharmacogenomics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the Pharmacogenomics market, request a sample here.

Who are the major players in the Pharmacogenomics market?

What are the key trends in the Pharmacogenomics market?

Major trends in the Pharmacogenomics market include Technological Advancements Transforming The Pharmacogenomics Market. For further insights on the Pharmacogenomics market, request a sample here.

What are the major opportunities in the Pharmacogenomics market? What are the strategies for the Pharmacogenomics market?

For detailed insights on the major opportunities and strategies in the Pharmacogenomics market, request a sample here.

How does the Pharmacogenomics market relate to the overall economy and other similar markets?

For detailed insights on Pharmacogenomics's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the Pharmacogenomics industry?

For detailed insights on the mergers and acquisitions in the Pharmacogenomics industry, request a sample here.

What are the key dynamics influencing the Pharmacogenomics market growth? SWOT analysis of the Pharmacogenomics market.

For detailed insights on the key dynamics influencing the Pharmacogenomics market growth and SWOT analysis of the Pharmacogenomics industry, request a sample here.